Plus Therapeutics (PSTV) Misses Q2 EPS by 1c

Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.01). Revenue for the quarter came in at $1.39 million.

For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.

You May Also Be Interested In

• OneConstruction Group (ONEG) Reports FY Loss of $0.84
• Virginia National Bankshares Corporation. (VABK) Tops Q2 EPS by 165c
• Eagle Financial Services, Inc. (EFSI) Misses Q2 EPS by 38c